Simms Michael J 4
4 · Alexza Pharmaceuticals Inc. · Filed Jan 21, 2011
Insider Transaction Report
Form 4
Simms Michael J
SVP, Operations & Manufact
Transactions
- Award
Common Stock
2011-01-19+45,582→ 76,309 total
Footnotes (1)
- [F1]Represents shares issued as restricted stock units (the "RSU") under the Issuer's 2005 Equity Incentive Plan (the "Plan") pursuant to the terms of the Issuer's 2009-2010 Performance Based Incentive Program (the "Performance Program"). The RSU will vest, and shares will be delivered to the Reporting Person, on the date the U.S. Food and Drug Administration approves the Issuer's New Drug Application for its AZ-004 (Staccato loxapine) product candidate, if ever, provided that at the relevant vesting date the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.